The SCIEX Echo MS+ and ZenoTOF 8600 systems redefine screening with one-second acoustic sampling and 10x sensitivity. By removing LC bottlenecks, this label-free platform accelerates drug discovery ...
Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Organoids, assembloids, and organ-on-a-chip technologies represent transformative advances in the fields of drug discovery, precision medicine, and ...
Scientists often turn to high throughput screening (HTS) to quickly assay large-scale compound libraries against a desired target, accelerating life science research. New technologies and relevant ...
As interest in CAR T cells and immune-based oncology therapies increases, efficient phenotyping of cell therapy products ...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, ...
Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results